HEALTH AND SAFETY
» Drug, Devices, and Supplements
» Physician Accountability
» Consumer Product Safety
» Worker Safety
» Health Care Delivery
» Auto and Truck Safety
» Global Access to Medicines
» Infant Formula Marketing
More information on troglitazone (Rezulin)
- Letter in the Lancet on the Availability of Information on Thiazolidinediones, July 15, 2000
- Letter Requesting a Criminal Investigation of Warner Lambert/Parke Davis, March 14, 2000
- Petition Requesting Updated Labeling for Diabetes drugs Troglitazone (Rezulin), Rosiglitazone (Avandia) and Pioglitazone (Actos), March 7, 2000
- Letter in JAMA Responding to Article on the Safety of Withdrawn Drugs, December 2, 1999
- Testimony Advising the FDA to Withdraw Troglitazone (Rezulin), March 26, 1999
- Letter on Ad for Troglitazone (Rezulin), January 6, 1999
- Petition to Ban Troglitazone (Rezulin), July 27, 1998